PAVmed Inc share price logo

PAVmed Inc Share Price

NASDAQ: PAVM

Small Cap

$9.20

-0.08

(-0.86%)

as on

PAVmed Inc Stock Performance

as on April 15, 2026 at 6:56 am IST

  • Day's Low

    Day's High

    $9.10
    $9.67
    downward going graph

    1.09%

    Downside

    5.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.00
    $28.44
    downward going graph

    34.78%

    Downside

    209.13%

    Upside

    downward going graph

PAVmed Inc share price movements today

Previous Close
$9.28
Open
$9.38
Volume
236.9K
Day's Low - High
$9.10 - $9.67
52 Week Low - High
$6.00 - $28.44

PAVmed Inc Historical Returns

1 Month Return
-9.02 %
3 Month Return
+ 0.98 %
1 Year Return
-57.05 %
3 Year Return
-95.31 %
5 Year Return
-99.58 %

PAVmed Inc Stock Fundamentals & Key Indicators

Check PAVmed Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$58.4M

EPS (TTM)

-2.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-21.7M

Revenue (TTM)

71.0K

Profit Margin

564.79%

Return On Equity TTM

-32.34%

PAVmed Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PAVmed Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
PAVmed Inc image
PAVmed Inc
BUY$58.4M-99.58%NA564.79%
Boston Scientific Corp image
Boston Scientific Corp
BUY$91.8B59.26%31.8514.44%
Stryker Corporation image
Stryker Corporation
BUY$129.9B37.64%40.3312.92%
Medtronic PLC image
Medtronic PLC
BUY$112.0B-28.97%24.3613.00%
Abbott Laboratories image
Abbott Laboratories
BUY$174.3B-17.13%26.9614.72%
See all

Stock Returns calculator for PAVmed Inc Stock including INR - Dollar returns

The PAVmed Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

PAVmed Inc investment value today

Current value as on today

₹46,053

Returns

-₹53,947

(-53.95%)

Returns from PAVmed Inc Stock

-₹57,427 (-57.43%)

Dollar Impact

₹3,480 (+3.48%)

Analyst Recommendation on PAVmed Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for PAVmed Inc. Average target price of $40.5

PAVmed Inc Share Price Target

Get share price movements and forecasts by analysts on PAVmed Inc.

What analysts predicted

77.28%UPSIDE

Target Price

$40.5

Current Price

$9.2

Analyzed by

10 Analysts

Target

$40.50

PAVmed Inc target price $40.5, a slight upside of 77.28% compared to current price of $9.2. According to 10 analysts rating.

PAVmed Inc Stock’s Investor Sentiment and Interest

Search interest for PAVmed Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

PAVmed Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
1
1
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-15
-16
-14
-13
-11
-5
-5
-4
-4
-6
EBITDA
-20
-16
-17
-14
60
1
18
-12
-5
-6
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-21
-17
-18
-14
60
1
18
-12
-6
-2
Income Tax Expense
-4
-3
4,276
-4,006
-3,605
-7,815
928
984
317
-
Net Income
-17
-14
-15
-10
64
1
18
-11
-5
-1
Net Profit Margin
-2234.01%
-1338.04%
-1506.14%
-1105.92%
6465.76%
14310.00%
237100.00%
-198683.33%
-107660.00%
-2428.85%

PAVmed Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
0
2
2
0
Gross Profit
0
0
0
0
0
0
-3
-3
-3
0
Operating Income
-5
-8
-10
-14
-23
-54
-91
-68
-44
-21
EBITDA
-5
-11
-12
-16
-23
-55
-99
-75
29
-21
Interest Expense
-
0
2
0
0
5
1
0
0
0
Depreciation
-
0
0
0
0
0
2
2
1
0
Income Before Tax
-5
-9
-18
-17
-35
-56
-103
-79
28
-2
Income Tax Expense
0
0
0
-1
-1
-5
-1
-12,993
-3,539
1,305
Net Income
-5
-9
-17
-15
-34
-50
-88
-64
39
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-10069.40%
-23602.92%
-2617.25%
1328.58%
564.79%

PAVmed Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-17
-18
-14
60
1
18
-12
-5
-33,370
Operating Cash Flow
-11
-13
-11
-8
0
-1
-1
0
-6,385
Investing Cash Flow
0
0
0
-16
0
0
0
0
0
Financing Cash Flow
5
19
11
0
0
3
2
0
8,083
Change in Cash
-6
5
0
-24
0
1
1
0
-1

PAVmed Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-18
-17
-35
-56
-103
-79
28
-2,469
Operating Cash Flow
-6
-8
-13
-21
-40
-70
-52
-33
-5,206
Investing Cash Flow
0
0
0
0
-3
-4
0
-16
-31
Financing Cash Flow
7
15
11
33
104
38
31
31
5,590
Change in Cash
0
6
-2
11
60
-37
-20
-18
353

Global Institutional Holdings in PAVmed Inc

Funds
Holdings
Susquehanna International Group, LLP
0.16%
XML Financial, LLC
0.02%
Geode Capital Management, LLC
0.23%
Atlantic Trust Group, LLC
0%
SIMPLEX TRADING, LLC
0%
See all

Insights on PAVmed Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -11.92M → -1.26M (in $), with an average increase of 223.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 5.0K → 52.0K (in $), with an average increase of 90.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 11.8% return, outperforming this stock by 68.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Pavmed Inc has experienced a drawdown of -95.3%, however Boston Scientific Corp. resisted the overall trend and outperformed by 87.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, PAVM stock has moved down by -95.3%

About PAVmed Inc

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York
OrganisationPAVmed Inc
Headquarters360 Madison Avenue, New York, NY, United States, 10017
IndustryMedical Devices
CEODr. Lishan Aklog M.D.
E-voting on sharesClick here to vote

Key Management of PAVmed Inc

Name

Title

Mr. Shaun M. O'Neill M.B.A.

Executive VP & COO

Dr. Deepika A. Lakhani Ph.D.

Senior VP, Chief Regulatory & Quality Officer

Dr. Victoria T. Lee M.D.

Senior VP & Chief Medical Officer

Mr. Matthew Riley

Senior Director of Investor Relations

Mr. Joseph Virgilio

SVP & Chief Business Officer of Medical Devices

Dr. Lishan Aklog M.D.

Chairman & CEO

Mr. Michael Adam Gordon

Executive VP, General Counsel & Secretary

Dr. Brian J. deGuzman M.D.

Executive VP, Chief Technology & Compliance Officer

Dr. Suman M. Verma M.D., Ph.D.

Senior VP of Molecular Genetics & Chief Scientific Officer

FAQs

What is PAVmed Inc share price today?

PAVmed Inc share price today is $9.2 as on at the close of the market. PAVmed Inc share today touched a day high of $9.67 and a low of $9.1.

What is the 52 week high and 52 week low for PAVmed Inc share?

PAVmed Inc share touched a 52 week high of $28.44 on and a 52 week low of $6 on . PAVmed Inc stock price today i.e. is closed at $9.2,which is 67.65% down from its 52 week high and 53.33% up from its 52 week low.

What is PAVmed Inc's market capitalisation today?

PAVmed Inc market capitalisation is $0.00T as on .

How to invest in PAVmed Inc Stock (PAVM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PAVmed Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PAVmed Inc Shares that will get you 0.1630 shares as per PAVmed Inc share price of $9.2 per share as on April 15, 2026 at 1:26 am IST.

What is the minimum amount required to buy PAVmed Inc Stock (PAVM) from India?

Indian investors can start investing in PAVmed Inc (PAVM) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in PAVmed Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on PAVmed Inc share’s latest price of $9.2 as on April 15, 2026 at 1:26 am IST, you will get 1.0870 shares of PAVmed Inc. Learn more about fractional shares .

What are the returns that PAVmed Inc has given to Indian investors in the last 5 years?

PAVmed Inc stock has given -99.58% share price returns and 24.21% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?